Skip to content

Customer Deposit at other companies

Bit Digital logo
Bit DigitalBTBT
$3.78M-20.6%
Marten Transport logo
Marten TransportMRTN
$5M
Kadant logo
KadantKAI
$64.47M+80.3%
VenHub Global, Inc.
 logo
VenHub Global, Inc. VHUB
$179.5K
Axon Enterprise, Inc. logo
Axon Enterprise, Inc.AXON
$18.13M-16.3%
Henry Schein logo
Henry ScheinHSIC
$4M0.0%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept flgt:CustomerDeposit.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s customer deposit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s customer deposit?
Fulgent Genetics, Inc. (FLGT) reported customer deposit of $30.62M in Q1 2026.
How has Fulgent Genetics, Inc.'s customer deposit changed year-over-year?
Fulgent Genetics, Inc.'s customer deposit increased by 10.6% year-over-year, from $27.7M to $30.62M.
What is the long-term trend for Fulgent Genetics, Inc.'s customer deposit?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s customer deposit has grown at a 173.2% compound annual growth rate (CAGR), from $185K to $28.15M.
What does customer deposit mean?
This represents funds received from clients in advance of laboratory testing services or diagnostic interpretations being performed. It serves as a measure of deferred revenue and reflects the company's ability to secure upfront commitments from healthcare providers and patients. High balances indicate strong pre-paid demand for genetic testing services.